322 related articles for article (PubMed ID: 31371360)
1. Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma.
Lee MD; Baird GL; Bell LC; Quarles CC; Boxerman JL
AJNR Am J Neuroradiol; 2019 Sep; 40(9):1445-1450. PubMed ID: 31371360
[TBL] [Abstract][Full Text] [Related]
2. Clinical Value of Vascular Permeability Estimates Using Dynamic Susceptibility Contrast MRI: Improved Diagnostic Performance in Distinguishing Hypervascular Primary CNS Lymphoma from Glioblastoma.
Lee B; Park JE; Bjørnerud A; Kim JH; Lee JY; Kim HS
AJNR Am J Neuroradiol; 2018 Aug; 39(8):1415-1422. PubMed ID: 30026384
[TBL] [Abstract][Full Text] [Related]
3. Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors.
Schmainda KM; Prah MA; Hu LS; Quarles CC; Semmineh N; Rand SD; Connelly JM; Anderies B; Zhou Y; Liu Y; Logan B; Stokes A; Baird G; Boxerman JL
AJNR Am J Neuroradiol; 2019 Apr; 40(4):626-633. PubMed ID: 30923088
[TBL] [Abstract][Full Text] [Related]
4. Validation of combined use of DWI and percentage signal recovery-optimized protocol of DSC-MRI in differentiation of high-grade glioma, metastasis, and lymphoma.
Cindil E; Sendur HN; Cerit MN; Dag N; Erdogan N; Celebi FE; Oner Y; Tali T
Neuroradiology; 2021 Mar; 63(3):331-342. PubMed ID: 32821962
[TBL] [Abstract][Full Text] [Related]
5. Discrimination between Glioblastoma and Solitary Brain Metastasis: Comparison of Inflow-Based Vascular-Space-Occupancy and Dynamic Susceptibility Contrast MR Imaging.
Li X; Wang D; Liao S; Guo L; Xiao X; Liu X; Xu Y; Hua J; Pillai JJ; Wu Y
AJNR Am J Neuroradiol; 2020 Apr; 41(4):583-590. PubMed ID: 32139428
[TBL] [Abstract][Full Text] [Related]
6. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
[TBL] [Abstract][Full Text] [Related]
7. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
[TBL] [Abstract][Full Text] [Related]
8. Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.
Hu LS; Kelm Z; Korfiatis P; Dueck AC; Elrod C; Ellingson BM; Kaufmann TJ; Eschbacher JM; Karis JP; Smith K; Nakaji P; Brinkman D; Pafundi D; Baxter LC; Erickson BJ
AJNR Am J Neuroradiol; 2015 Dec; 36(12):2242-9. PubMed ID: 26359151
[TBL] [Abstract][Full Text] [Related]
9. Effects of MRI Protocol Parameters, Preload Injection Dose, Fractionation Strategies, and Leakage Correction Algorithms on the Fidelity of Dynamic-Susceptibility Contrast MRI Estimates of Relative Cerebral Blood Volume in Gliomas.
Leu K; Boxerman JL; Ellingson BM
AJNR Am J Neuroradiol; 2017 Mar; 38(3):478-484. PubMed ID: 28034995
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction.
Toh CH; Wei KC; Chang CN; Ng SH; Wong HF
AJNR Am J Neuroradiol; 2013; 34(6):1145-9. PubMed ID: 23348763
[TBL] [Abstract][Full Text] [Related]
11. Improved performance of non-preloaded and high flip-angle dynamic susceptibility contrast perfusion-weighted imaging sequences in the presurgical differentiation of brain lymphoma and glioblastoma.
Wang F; Zhou X; Chen R; Kang J; Yang X; Lin J; Liu F; Cao D; Xing Z
Eur Radiol; 2023 Dec; 33(12):8800-8808. PubMed ID: 37439934
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric analysis from dynamic susceptibility contrast-enhanced perfusion MRI to evaluate malignant brain tumors.
Abreu VS; Tarrio J; Silva J; Almeida F; Pinto C; Freitas D; Filipe JP
J Neuroimaging; 2024; 34(2):257-266. PubMed ID: 38173078
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
Xing Z; You RX; Li J; Liu Y; Cao DR
Clin Neuroradiol; 2014 Dec; 24(4):329-36. PubMed ID: 23994941
[TBL] [Abstract][Full Text] [Related]
14. Optimization of Acquisition and Analysis Methods for Clinical Dynamic Susceptibility Contrast MRI Using a Population-Based Digital Reference Object.
Semmineh NB; Bell LC; Stokes AM; Hu LS; Boxerman JL; Quarles CC
AJNR Am J Neuroradiol; 2018 Nov; 39(11):1981-1988. PubMed ID: 30309842
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of brain abscesses from glioblastomas and metastatic brain tumors: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging before and after mathematic contrast leakage correction.
Toh CH; Wei KC; Chang CN; Ng SH; Wong HF; Lin CP
PLoS One; 2014; 9(10):e109172. PubMed ID: 25330386
[TBL] [Abstract][Full Text] [Related]
16. Presurgical Identification of Primary Central Nervous System Lymphoma with Normalized Time-Intensity Curve: A Pilot Study of a New Method to Analyze DSC-PWI.
Pons-Escoda A; Garcia-Ruiz A; Naval-Baudin P; Cos M; Vidal N; Plans G; Bruna J; Perez-Lopez R; Majos C
AJNR Am J Neuroradiol; 2020 Oct; 41(10):1816-1824. PubMed ID: 32943424
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.
Neska-Matuszewska M; Bladowska J; Sąsiadek M; Zimny A
PLoS One; 2018; 13(1):e0191341. PubMed ID: 29342201
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between primary central nervous system lymphoma and glioblastoma: a comparative study of parameters derived from dynamic susceptibility contrast-enhanced perfusion-weighted MRI.
Nakajima S; Okada T; Yamamoto A; Kanagaki M; Fushimi Y; Okada T; Arakawa Y; Takagi Y; Miyamoto S; Togashi K
Clin Radiol; 2015 Dec; 70(12):1393-9. PubMed ID: 26382744
[TBL] [Abstract][Full Text] [Related]
19. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
[TBL] [Abstract][Full Text] [Related]
20. Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project.
Schmainda KM; Prah MA; Rand SD; Liu Y; Logan B; Muzi M; Rane SD; Da X; Yen YF; Kalpathy-Cramer J; Chenevert TL; Hoff B; Ross B; Cao Y; Aryal MP; Erickson B; Korfiatis P; Dondlinger T; Bell L; Hu L; Kinahan PE; Quarles CC
AJNR Am J Neuroradiol; 2018 Jun; 39(6):1008-1016. PubMed ID: 29794239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
